169 related articles for article (PubMed ID: 31133447)
1. Risk Factors for Macroscopic Haemoglobinuria After Sclerotherapy Using Ethanolamine Oleate for Venous Malformations.
Fujiki M; Ozaki M; Kurachi I; Iwashina Y; Takushima A
Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):105-111. PubMed ID: 31133447
[TBL] [Abstract][Full Text] [Related]
2. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures.
Barranco-Pons R; Burrows PE; Landrigan-Ossar M; Trenor CC; Alomari AI
AJR Am J Roentgenol; 2012 Sep; 199(3):691-4. PubMed ID: 22915413
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.
Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
J Vasc Surg; 2008 Mar; 47(3):578-84. PubMed ID: 18295109
[TBL] [Abstract][Full Text] [Related]
4. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
Kishi K; Morita N; Terada T; Sato M
Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and complications of sclerotherapy for venous malformations.
Qiu Y; Chen H; Lin X; Hu X; Jin Y; Ma G
Vasc Endovascular Surg; 2013 Aug; 47(6):454-61. PubMed ID: 23759722
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and evaluation of safety of sclerosants for intramuscular venous malformations: clinical and experimental studies.
Ozaki M; Kurita M; Kaji N; Fujino T; Narushima M; Takushima A; Harii K
Scand J Plast Reconstr Surg Hand Surg; 2010 Apr; 44(2):75-87. PubMed ID: 20465508
[TBL] [Abstract][Full Text] [Related]
7. Treatment of venous malformations with ethanolamine oleate.
Das BK; Hoque S
Asian J Surg; 2008 Oct; 31(4):220-4. PubMed ID: 19010768
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous sclerotherapy with ethanolamine oleate for venous malformations of the head and neck.
Alexander MD; McTaggart RA; Choudhri OA; Marcellus ML; Do HM
J Neurointerv Surg; 2014 Nov; 6(9):695-8. PubMed ID: 24235099
[TBL] [Abstract][Full Text] [Related]
9. Sclerotherapy with Adjunctive Stasis of Efflux (STASE) in Venous Malformations: Techniques and Strategies.
Legiehn GM
Tech Vasc Interv Radiol; 2019 Dec; 22(4):100630. PubMed ID: 31864535
[TBL] [Abstract][Full Text] [Related]
10. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
Li L; Feng J; Zeng XQ; Li YH
J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
[TBL] [Abstract][Full Text] [Related]
11. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
[TBL] [Abstract][Full Text] [Related]
12. Sclerotherapy of peripheral venous malformations: a new technique to prevent serious complications.
Ierardi AM; Mangini M; Vaghi M; Cazzulani A; Carrafiello G; Mattassi R
Vasc Endovascular Surg; 2010 May; 44(4):282-8. PubMed ID: 20403950
[TBL] [Abstract][Full Text] [Related]
13. Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents.
Horbach SE; Lokhorst MM; Saeed P; de Goüyon Matignon de Pontouraude CM; Rothová A; van der Horst CM
J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):295-304. PubMed ID: 26723834
[TBL] [Abstract][Full Text] [Related]
14. Venous malformation of the tongue in a child treated by sclerotherapy with ethanolamine oleate: a case report.
Nishikawa M; Sakamoto K; Hidaka M; Yamashita A; Yamamoto G
J Pediatr Surg; 2006 Mar; 41(3):599-600. PubMed ID: 16516646
[TBL] [Abstract][Full Text] [Related]
15. Sclerotherapy in venous malformation.
Rabe E; Pannier F
Phlebology; 2013 Mar; 28 Suppl 1():188-91. PubMed ID: 23482557
[TBL] [Abstract][Full Text] [Related]
16. Reactive vascular lesions treated using ethanolamine oleate sclerotherapy.
Hong SK; Lee HJ; Seo JK; Lee D; Hwang SW; Sung HS
Dermatol Surg; 2010 Jul; 36(7):1148-52. PubMed ID: 20533938
[TBL] [Abstract][Full Text] [Related]
17. [Study on the usefulness of haptoglobin used on endoscopic injection sclerotherapy].
Matsumoto A; Miyoshi H; Takada K; Hayashi K; Asada S; Hirata I; Ohshiba S
Nihon Shokakibyo Gakkai Zasshi; 1990 Jun; 87(6):1343-9. PubMed ID: 2214258
[TBL] [Abstract][Full Text] [Related]
18. Intralesional sclerotherapy for subcutaneous venous malformations in children.
Uehara S; Osuga K; Yoneda A; Oue T; Yamanaka H; Fukuzawa M
Pediatr Surg Int; 2009 Aug; 25(8):709-13. PubMed ID: 19582463
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Venous Malformations: The Data, Where We Are, and How It Is Done.
Hage AN; Chick JFB; Srinivasa RN; Bundy JJ; Chauhan NR; Acord M; Gemmete JJ
Tech Vasc Interv Radiol; 2018 Jun; 21(2):45-54. PubMed ID: 29784122
[TBL] [Abstract][Full Text] [Related]
20. Experience of sclerotherapy and embolosclerotherapy using ethanolamine oleate for vascular malformations of the head and neck.
Kaji N; Kurita M; Ozaki M; Takushima A; Harii K; Narushima M; Wakita S
Scand J Plast Reconstr Surg Hand Surg; 2009; 43(3):126-36. PubMed ID: 19401940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
